News

The Food and Drug Administration on Friday approved two gene therapies to treat sickle cell disease, one of the which is the first CRISPR/Cas9-based treatment to win regulatory approval in the US. The ...
In the ever-evolving realm of modern medicine, a once-distant dream to conquer disease through genetics has now inched closer to reality. Last Friday, the U.S. Food and Drug Administration approved ...
Researchers have been able to manipulate large chunks of genetic code for almost 50 years. But it is only within the past decade that they have been able to do it with exquisite precision – adding, ...
New research overturns a common assumption about CRISPR Cas9—that unbound from its usual RNA partners, the “empty” or apo form of Cas9 is functionless.
Scientists identify a new CARF effector, Cat1, with a complex structure that depletes a key metabolite, halting viral replication by cutting off its energy supply. (Nanowerk News) Every living ...
An explanation of how the cutting-edge gene editing tool works. Sweeping ICE Arrests in Blow to Immigration Crisis Dramatic video shows Royal Navy warship HMS Dragon shooting down supersonic missile ...
On the show today, the Food and Drug Administration expanded its approval for CRISPR gene-editing therapies. We look at the affordability of these treatments, which can cost well into the millions of ...